5 Key Takeaways
-
1
The refractive surgery market is projected to grow at a CAGR of 3.9%, reaching a valuation of $312.3 million by 2034.
-
2
Myopia is the leading cause of visual impairment globally, affecting approximately 4% of the U.S. population.
-
3
A diverse range of refractive procedures, including LASIK, PRK, SMILE, and ICL, is essential to meet varying patient needs.
-
4
Technological advancements and increased patient awareness are key factors driving the demand for refractive surgery.
-
5
ICL surgery offers high correction levels and preserves corneal integrity, making it a favorable option for a broad range of refractive errors.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







